Valneva SE (VALN) Common Equity (2020 - 2026)

Valneva SE's (VALN) quarterly Common Equity came in at $89.8 million in Q1 2026, down 51.29% year-on-year from $184.3 million in Q1 2025, and down 27.34% quarter-over-quarter from $123.6 million in Q4 2025.

Valneva SE (VALN) Common Equity (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Common Equity across 7 years of filings, most recently posting $89.8 million for Q1 2026.

  • Common Equity for Q1 2026 came in at $89.8 million, down 51.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $89.8 million (down 51.29% YoY), and the FY2025 annual result was $123.6 million, down 36.19% from the prior year.
  • Common Equity came in at $89.8 million for Q1 2026 at Valneva SE, down from $123.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $505.8 million in Q3 2022 to a low of $89.8 million in Q1 2026.
  • The 5-year median for Common Equity is $189.0 million (2024), against an average of $203.5 million.
  • Across the five-year window, Common Equity tumbled 66.1% in 2023 and jumped 40.37% in 2024, its largest moves.
  • Valneva SE's Common Equity stood at $224.2 million in 2022, then tumbled by 38.47% to $138.0 million in 2023, then jumped by 40.37% to $193.7 million in 2024, then tumbled by 36.19% to $123.6 million in 2025, then slipped by 27.34% to $89.8 million in 2026.
  • The last three Common Equity figures came in at $89.8 million (Q1 2026), $123.6 million (Q4 2025), and $175.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 35.63 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -1.42 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 13.21 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 89.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 89.80 Mn
Dec 31, 2025 123.58 Mn
Sep 30, 2025 175.92 Mn
Jun 30, 2025 211.03 Mn
Mar 31, 2025 184.35 Mn
Dec 31, 2024 193.69 Mn
Sep 30, 2024 238.83 Mn
Jun 30, 2024 179.06 Mn
Mar 31, 2024 205.57 Mn
Dec 31, 2023 137.99 Mn
Sep 30, 2023 171.48 Mn
Jun 30, 2023 207.67 Mn
Dec 31, 2022 224.25 Mn
Sep 30, 2022 505.79 Mn
Dec 31, 2021 195.14 Mn
Sep 30, 2021 387.64 Mn
Dec 31, 2020 92.31 Mn